Feasibility of treatment-free remission with generic imatinib: Results of generic imatinib-free trial-in-chronic myeloid leukaemia-chronic phase study.

Deepak Goni,Arihant Jain,Charanpreet Singh,Nishant Jindal,Ram Nampoothiri,Aditya Jandial,Deepesh Lad,Alka Khadwal,Gaurav Prakash,Shano Naseem,Neelam Varma,Pankaj Malhotra

The Indian journal of medical research（2023）

引用 2|浏览5

暂无评分

摘要

The study adds to the growing literature that generic imatinib is effective and can be safely discontinued in CML-CP patients who are in deep molecular remission.

查看译文

关键词

Chronic myeloid leukaemia - generic imatinib - treatment-free remission

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要